
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
---|---|---|---|---|---|---|
Revenue | $64.3M | $58.8M | $12.8M | $13.1M | $6.9M | |
Revenue Growth (YoY) | -- | -8.61% | -78.29% | 2.55% | -47.38% | |
Cost of Revenues | $54.3M | $46.8M | $11.5M | $10.5M | $4.3M | |
Gross Profit | $10.1M | $11.9M | $1.2M | $2.6M | $2.6M | |
Gross Profit Margin | 15.64% | 20.3% | 9.73% | 19.67% | 37.83% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.7M | $22.4M | $15.6M | $13.2M | $8.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$241.2K | |
Operating Expenses | $4.7M | $22.4M | $15.6M | $13.2M | $8.3M | |
Operating Income | $5.4M | -$10.5M | -$14.4M | -$10.7M | -$5.7M | |
Net Interest Expenses | -- | -- | -- | $466.5K | $729.6K | |
EBT. Incl. Unusual Items | $5.4M | -$10.5M | -$14.4M | -$11.1M | -$6.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.5M | -$1.4M | -$18.3K | $2.4K | $19.7K | |
Net Income to Company | $3.8M | -$9M | -$14.4M | -$11.1M | -$6.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $3.8M | -$9M | -$14.4M | -$11.1M | -$6.7M | |
Basic EPS (Cont. Ops) | $1.89 | -$7.98 | -$7.60 | -$4.13 | -$1.62 | |
Diluted EPS (Cont. Ops) | $1.89 | -$7.98 | -$7.60 | -$4.13 | -$1.62 | |
Weighted Average Basic Share | $2M | $1.1M | $1.9M | $2.7M | $4.3M | |
Weighted Average Diluted Share | $2M | $1.1M | $1.9M | $2.7M | $4.3M | |
EBITDA | $5.4M | -$10.5M | -$14.4M | -$10.3M | -$5.2M | |
EBIT | $5.4M | -$10.5M | -$14.4M | -$10.7M | -$6M | |
Revenue (Reported) | $64.3M | $58.8M | $12.8M | $13.1M | $6.9M | |
Operating Income (Reported) | $5.4M | -$10.5M | -$14.4M | -$10.7M | -$5.7M | |
Operating Income (Adjusted) | $5.4M | -$10.5M | -$14.4M | -$10.7M | -$6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $18.1M | $3.1M | $3M | $2.2M | $47.1K | |
Revenue Growth (YoY) | -19.36% | -83.14% | -1.3% | -26.29% | -97.89% | |
Cost of Revenues | $11.9M | $2.7M | $3.1M | $1.7M | -- | |
Gross Profit | $6.3M | $387.7K | -$125.4K | $499.7K | $47.1K | |
Gross Profit Margin | 34.64% | 12.67% | -4.15% | 22.44% | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.4M | $5.4M | $3.8M | $1.8M | $1.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$709.4K | |
Operating Expenses | $10.4M | $5.4M | $3.8M | $1.8M | $1.3M | |
Operating Income | -$4.1M | -$5M | -$4M | -$1.3M | -$1.3M | |
Net Interest Expenses | -- | -- | -- | $271.5K | $4.1K | |
EBT. Incl. Unusual Items | -$4.1M | -$5M | -$4M | -$1.5M | -$2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $186.8K | -$5.8K | -- | -- | -- | |
Net Income to Company | -$4.3M | -$5M | -$4M | -$1.5M | -$2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.3M | -$5M | -$4M | -$1.5M | -$2M | |
Basic EPS (Cont. Ops) | -$3.78 | -$3.36 | -$1.48 | -$0.56 | -$0.17 | |
Diluted EPS (Cont. Ops) | -$3.78 | -$3.36 | -$1.48 | -$0.56 | -$0.17 | |
Weighted Average Basic Share | $1.1M | $1.5M | $2.7M | $2.9M | $11.5M | |
Weighted Average Diluted Share | $1.1M | $1.5M | $2.7M | $2.9M | $11.5M | |
EBITDA | -$4.1M | -$5M | -$4M | -$1.1M | -$1.8M | |
EBIT | -$4.1M | -$5M | -$4M | -$1.3M | -$2M | |
Revenue (Reported) | $18.1M | $3.1M | $3M | $2.2M | $47.1K | |
Operating Income (Reported) | -$4.1M | -$5M | -$4M | -$1.3M | -$1.3M | |
Operating Income (Adjusted) | -$4.1M | -$5M | -$4M | -$1.3M | -$2M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $97.3M | $9.2M | $12.4M | $13M | $1.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $78.7M | $8.6M | $10.4M | $9.1M | -- | |
Gross Profit | $18.6M | $547.8K | $2M | $3.9M | $1.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $19M | $15.2M | $15.5M | $10.5M | $9.3M | |
Other Inc / (Exp) | -- | -- | -- | -$98.4K | -$852.2K | |
Operating Expenses | $19M | $15.2M | $15.5M | $10.5M | $9.3M | |
Operating Income | -$361.6K | -$14.6M | -$13.6M | -$6.7M | -$8.1M | |
Net Interest Expenses | -- | -- | -- | $1M | $166.4K | |
EBT. Incl. Unusual Items | -$360.2K | -$14.6M | -$13.5M | -$7.8M | -$9.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $857.5K | -$1.7M | -$12.5K | $3.1K | -- | |
Net Income to Company | -$2.9M | -$12.9M | -$13.5M | -$7.8M | -$9.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.2M | -$12.9M | -$13.5M | -$7.8M | -$9.1M | |
Basic EPS (Cont. Ops) | -$2.31 | -$9.66 | -$4.95 | -$2.86 | -$1.16 | |
Diluted EPS (Cont. Ops) | -$2.31 | -$9.66 | -$4.95 | -$2.86 | -$1.16 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$361.6K | -$14.6M | -$13.6M | -$6M | -$8.2M | |
EBIT | -$361.6K | -$14.6M | -$13.6M | -$6.8M | -$9M | |
Revenue (Reported) | $97.3M | $9.2M | $12.4M | $13M | $1.7M | |
Operating Income (Reported) | -$361.6K | -$14.6M | -$13.6M | -$6.7M | -$8.1M | |
Operating Income (Adjusted) | -$361.6K | -$14.6M | -$13.6M | -$6.8M | -$9M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $55.5M | $5.9M | $5.5M | $5.4M | $249.7K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $44.4M | $6.2M | $5.1M | $3.7M | -- | |
Gross Profit | $11.1M | -$303.2K | $414.8K | $1.7M | $249.7K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $14.7M | $7.5M | $7.4M | $4.7M | $5.6M | |
Other Inc / (Exp) | -- | -- | -- | -$98.4K | -$709.4K | |
Operating Expenses | $14.7M | $7.5M | $7.4M | $4.7M | $5.6M | |
Operating Income | -$3.7M | -$7.8M | -$7M | -$3M | -$5.4M | |
Net Interest Expenses | -- | -- | -- | $571.4K | $8.2K | |
EBT. Incl. Unusual Items | -$3.7M | -$7.8M | -$7M | -$3.6M | -$6.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $293.2K | -$5.8K | -- | $720 | -$18.9K | |
Net Income to Company | -$3.9M | -$7.8M | -$7M | -$3.6M | -$6.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3.9M | -$7.8M | -$7M | -$3.6M | -$6.1M | |
Basic EPS (Cont. Ops) | -$3.57 | -$5.25 | -$2.60 | -$1.32 | -$0.60 | |
Diluted EPS (Cont. Ops) | -$3.57 | -$5.25 | -$2.60 | -$1.32 | -$0.60 | |
Weighted Average Basic Share | $2.2M | $2.9M | $5.3M | $5.7M | $21M | |
Weighted Average Diluted Share | $2.2M | $2.9M | $5.3M | $5.7M | $21M | |
EBITDA | -$3.7M | -$7.8M | -$7M | -$2.7M | -$5.7M | |
EBIT | -$3.7M | -$7.8M | -$7M | -$3.1M | -$6.1M | |
Revenue (Reported) | $55.5M | $5.9M | $5.5M | $5.4M | $249.7K | |
Operating Income (Reported) | -$3.7M | -$7.8M | -$7M | -$3M | -$5.4M | |
Operating Income (Adjusted) | -$3.7M | -$7.8M | -$7M | -$3.1M | -$6.1M |
Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.4M | $7.8M | $3.7M | $533.7K | $3.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.4M | $2M | $574.6K | $1.9M | $263.6K | |
Inventory | $6.4K | $15.3M | $1.2M | $4.1M | -- | |
Prepaid Expenses | -- | $3.2M | $426.4K | $430.7K | $344.3K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $8.8M | $30.1M | $9.1M | $6.9M | $4.5M | |
Property Plant And Equipment | $70.1K | $55.6K | $1.2M | $1M | $812.2K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $8.9M | $30.2M | $12.4M | $19.4M | $16M | |
Accounts Payable | -- | $242.8K | $40K | $374.3K | $57.5K | |
Accrued Expenses | $1.1M | $579.6K | $1.1M | $736.2K | $925.6K | |
Current Portion Of Long-Term Debt | -- | -- | -- | $799.5K | -- | |
Current Portion Of Capital Lease Obligations | $11.7K | $13K | $166.1K | $184.6K | $203.9K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $4.4M | $13.8M | $1.6M | $5M | $1.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5M | $13.9M | $2.6M | $5.8M | $2.2M | |
Common Stock | $26.1K | $33.2K | $2.7K | $3.7K | $9.4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $4.4M | $16.3M | $9.8M | $13.6M | $13.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.4M | $16.3M | $9.8M | $13.6M | $13.8M | |
Total Liabilities and Equity | $8.9M | $30.2M | $12.4M | $19.4M | $16M | |
Cash and Short Terms | $7.4M | $7.8M | $3.7M | $533.7K | $3.9M | |
Total Debt | -- | -- | -- | $799.5K | $207.6K |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1M | $4.7M | $1.1M | $488.1K | $1.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $18.1M | $1.2M | $1.5M | $651.1K | $70K | |
Inventory | $28.8M | $9.2M | $3.6M | $598.2K | -- | |
Prepaid Expenses | $30K | $375.9K | $181.9K | $164.3K | $65.5K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $49.1M | $17.2M | $7.9M | $1.9M | $1.9M | |
Property Plant And Equipment | $62.9K | $48.3K | $1.1M | $912.8K | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $49.2M | $17.3M | $10.8M | $13.9M | $12.2M | |
Accounts Payable | $272.5K | $224.8K | $163.3K | $472.5K | $105.7K | |
Accrued Expenses | $1.6M | $467.1K | $696.9K | $624.4K | $679.9K | |
Current Portion Of Long-Term Debt | -- | -- | -- | $281.9K | -- | |
Current Portion Of Capital Lease Obligations | $12.4K | $13.7K | $175.2K | $194.1K | $214K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $39.9M | $4.1M | $4.2M | $3.3M | $1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $39.9M | $4.1M | $5.2M | $4M | $1.6M | |
Common Stock | $285.8K | $34.2K | $56.2K | $3.8K | $12.4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $9.2M | $13.2M | $5.6M | $9.9M | $10.6M | |
Total Liabilities and Equity | $49.2M | $17.3M | $10.8M | $13.9M | $12.2M | |
Cash and Short Terms | $2.1M | $4.7M | $1.1M | $488.1K | $1.8M | |
Total Debt | -- | -- | -- | $281.9K | -- |
Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.8M | -$9M | -$14.4M | -$11.1M | -$6.7M | |
Depreciation & Amoritzation | -- | -- | -- | $328.3K | $787.1K | |
Stock-Based Compensation | $769.4K | $11.2M | $6.3M | $3.4M | $170.2K | |
Change in Accounts Receivable | -$1.4M | -$2.3M | -$2.1M | $4M | $1.6M | |
Change in Inventories | -$6.4K | -$15.3M | $13.8M | -$3.3M | $4M | |
Cash From Operations | $7.6M | -$9.3M | -$5.7M | -$3M | -$672.6K | |
Capital Expenditures | -- | -- | -- | $3.5K | -- | |
Cash Acquisitions | -- | -- | -- | -$312.3K | -- | |
Cash From Investing | -- | -- | -- | -$315.8K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $1.3M | $1.1M | |
Long-Term Debt Repaid | -- | -- | -- | -$1.1M | -$2.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$745K | |
Cash From Financing | -$179.9K | $9.7M | $1.6M | $136.8K | $4M | |
Beginning Cash (CF) | -- | $7.4M | $7.8M | $3.7M | $533.7K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $7.4M | $403.5K | -$4.1M | -$3.2M | $3.4M | |
Ending Cash (CF) | $7.4M | $7.8M | $3.7M | $533.7K | $3.9M | |
Levered Free Cash Flow | $7.6M | -$9.3M | -$5.7M | -$3M | -$672.6K |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.3M | -$5M | -$4M | -$1.5M | -$2M | |
Depreciation & Amoritzation | -- | -- | $170 | $196.8K | $196.8K | |
Stock-Based Compensation | $7.7M | $2.7M | $1.4M | -$289.1K | $2.5K | |
Change in Accounts Receivable | -$5.5M | $120.6K | -$730.7K | -$42.2K | $136.9K | |
Change in Inventories | -$28.8M | $2.6M | $9.7K | $1.5M | -- | |
Cash From Operations | $224.3K | -$2.5M | -$2.6M | $470.5K | -$578.2K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$573.7K | -$43.7K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$47.5K | $1.5M | -- | -$573.7K | -$43.7K | |
Beginning Cash (CF) | $2M | $5.7M | $3.8M | $591.3K | $2.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $176.8K | -$928.9K | -$2.6M | -$103.2K | -$621.9K | |
Ending Cash (CF) | $2.1M | $4.7M | $1.1M | $488.1K | $1.8M | |
Levered Free Cash Flow | $224.3K | -$2.5M | -$2.6M | $470.5K | -$578.2K |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.9M | -$12.9M | -$13.5M | -$7.8M | -$9.1M | |
Depreciation & Amoritzation | -- | -- | $300 | $721.6K | $787.1K | |
Stock-Based Compensation | $9.6M | $5.5M | $6M | $681.5K | $3M | |
Change in Accounts Receivable | -$14.9M | $15.2M | -$1.8M | $3.9M | $688.1K | |
Change in Inventories | -$28.8M | $19.6M | $5.2M | $2.7M | $541.1K | |
Cash From Operations | $427.9K | -$8.7M | -$3.7M | $300.2K | -$2.9M | |
Capital Expenditures | -- | -- | $3.5K | -- | -- | |
Cash Acquisitions | -- | -- | -- | -$312.3K | -- | |
Cash From Investing | -- | -- | -$3.5K | -$312.3K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$405K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $2.4M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$3M | -$1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$257.9K | $11.3M | $59.4K | -$624.2K | $4.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $170K | $2.6M | -$3.6M | -$636.3K | $1.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $427.9K | -$8.7M | -$3.7M | $300.2K | -$2.9M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.9M | -$7.8M | -$7M | -$3.6M | -$6.1M | |
Depreciation & Amoritzation | -- | -- | $290 | $393.5K | $393.6K | |
Stock-Based Compensation | $8.8M | $3.1M | $2.8M | $82.9K | $2.9M | |
Change in Accounts Receivable | -$16.7M | $809.6K | $1.1M | $1.1M | $193.6K | |
Change in Inventories | -$28.8M | $6.1M | -$2.5M | $3.5M | -- | |
Cash From Operations | -$5.2M | -$4.6M | -$2.6M | $715.4K | -$1.5M | |
Capital Expenditures | -- | -- | $3.5K | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$3.5K | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$405K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.1M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$1.9M | -$207.6K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$78K | $1.5M | -- | -$761K | -$612.6K | |
Beginning Cash (CF) | $9.4M | $13.5M | $7.5M | $1.1M | $6.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.3M | -$3.1M | -$2.6M | -$45.6K | -$2.1M | |
Ending Cash (CF) | $4.1M | $10.4M | $4.9M | $1.1M | $4.2M | |
Levered Free Cash Flow | -$5.2M | -$4.6M | -$2.6M | $715.4K | -$1.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.